Erick Riquelme Sánchez | Postgrados - Universidad Mayor
Postgrado

Director Erick Riquelme Sánchez

eDiplomado en Microbioma para la Salud y la Enfermedad

erick.riquelme@umayor.cl Linkedin

PhD en ciencias Biológicas en la Universidad Catolica de Chile. Posteriormente se traslado al MD Anderson Cancer Center, USA donde desarrollo su postdoctorado estudiando mecanismos moleculares de resistencia a la terapias antitumorales.

Trayectoria

Present Title and Affiliation

Assistant Professor, Center for Integrative Biology, Universidad Mayor, Camino La Piramide 5750
Huechuraba 8580745, Santiago, Chile

 Positions and Employment

2001-2005 Medical Technology, Pontificia Universidad Católica de Chile. I was responsible for molecular diagnostic and research in human tumor samples
2005-2010 Postdoctoral Fellow Research Biomedical Research Consortium, Pontificia Universidad Católica de Chile. I was responsible for investigating molecular characterization of chemokines in thyroid cancer
2010-2016 Postdoctoral Fellow, UT MD Anderson Cancer Center, Houston, TX. Molecular mechanisms associated with resistance to therapy in non-small cell lung cancer (NSCLC)
2016-2019 Research Scientific, Department of Clinical Cancer Prevention, UT MD Anderson Cancer Center
March 2019-Present Assistant Professor, Center for Integrative Biology, Universidad Mayor

 Education

Degree-Granting Education

2001 Medical Technology Degree, University of Chile, Santiago, Chile
2007 Master in Biological Science, Pontificia Universidad Católica de Chile, Santiago, Chile
2009 Ph.D., Biological Science, Molecular Genetic and Microbiology. Pontificia Universidad Católica de Chile, Santiago, Chile

Postgraduate Training

2009-2010 Postdoctoral Fellow, UT MD Anderson Cancer Center, Houston, TX. Molecular mechanisms associated with resistance to therapy in non-small cell lung cancer (NSCLC)

Memberships

2010-Present American Association for Cancer Research, AACR

Honors

2005-2009 CONICYT Doctoral Fellowship, Santiago, Chile
2011-2012 Becas Chile Post-Doctoral Fellowship, Santiago, Chile

Project

FONDECYT Regular, 1191526

Publicaciones

  • Tumor Microbiome Diversity and Composition influence Pancreatic Cancer Outcomes. Cell. 2019 Aug 8;178(4):795-806. |

  • Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome JAMA Oncol. 2018 Apr 16 | PDF

  • Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling Cancer Discov. 2018 Apr;8(4):386-388 | PDF

  • Immunological regulation of stemness in pancreatic progenitor cells Gastroenterology. 2018 Jul; 155(1):210-223. | PDF

  • Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients Science. 2017 Nov 2 | PDF